EUVIMEDEUVIMED entdecken
Crossref

Biomimetic Cancer-Targeting Nanoplatform Boosting AIEgens-Based Photodynamic Therapy and Ferroptosis by Disrupting Redox-Homeostasis

Yu Wan iD, Yifei Cao, Dandan Hu, Qiuyue Lai, Yumeng Liu, Yuan Chen, Mingyu Wu iD, Shun Feng iD

ACS Biomaterials Science & Engineering · 2024

DOI: 10.1021/acsbiomaterials.4c00376 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Biomaterials Science & Engineering, 2024. Verfasst von Yu Wan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Sichuan Engineering Research Center for Biomimetic Synthesis of Natural Drugs, School of Life Science and Engineering, Southwest Jiaotong University,…. Hauptthemen laut MEDLINE: Ferroptosis, Photochemotherapy, Oxidation-Reduction, Photosensitizing Agents. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Southwest Jiaotong University, Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Photodynamic therapy (PDT) using aggregation-induced emission photosensitizer (AIE-PS) holds tremendous potential but is limited by its inherent disadvantages and the high concentrations of reduced glutathione (GSH) in tumor cells that can neutralize ROS to weaken PDT. Herein, we designed a nanodelivery system (CM-HSADSP@[PS-Sor]) in which albumin was utilized as a carrier for hydrophobic drug AIE-PS and Sorafenib, cross-linkers with disulfide bonds were introduced to form a nanogel core, and then cancer cell membranes were wrapped on its surface to confer homologous tumor targeting ability. A two-way strategy was employed to disturb redox-homeostasis through blocking GSH synthesis by Sorafenib and consuming excess GSH via abundant disulfide bonds, thereby promoting the depletion of GSH, which in turn increased the ROS levels in cancer cells to amplify the efficacy of ferroptosis and PDT, achieving an efficient in vivo antibreast cancer effect. This study brings a new strategy for ROS-based cancer therapy and expands the application of an albumin-based drug delivery system.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisPhotochemotherapyOxidation-ReductionPhotosensitizing AgentsHumansAnimalsReactive Oxygen SpeciesMiceCell Line, TumorGlutathioneHomeostasisNanoparticlesNeoplasmsMice, Inbred BALB CDrug Delivery SystemsSorafenib

Stichwörter der Autor:innen

AIEgenalbumin nanoparticlesferroptosis

Substanzen

Photosensitizing AgentsReactive Oxygen SpeciesGlutathioneSorafenib

Autor:innen und Institutionen

  • Sichuan Engineering Research Center for Biomimetic Synthesis of Natural Drugs, School of Life Science and Engineering, Southwest Jiaotong University, Chengdu 610031, China.

ORCID-Profile: Yu Wan, Mingyu Wu, Shun Feng

Förderung

  • Southwest Jiaotong University
  • Fundamental Research Funds for the Central Universities
  • National Natural Science Foundation of China

Zitieren

APA

Wan, Y., Cao, Y., Hu, D., Lai, Q., Liu, Y., Chen, Y., Wu, M., & Feng, S. (2024). Biomimetic Cancer-Targeting Nanoplatform Boosting AIEgens-Based Photodynamic Therapy and Ferroptosis by Disrupting Redox-Homeostasis. ACS Biomaterials Science & Engineering. https://doi.org/10.1021/acsbiomaterials.4c00376

Vancouver

Wan Y, Cao Y, Hu D, Lai Q, Liu Y, Chen Y, et al. Biomimetic Cancer-Targeting Nanoplatform Boosting AIEgens-Based Photodynamic Therapy and Ferroptosis by Disrupting Redox-Homeostasis. ACS Biomaterials Science & Engineering. 2024. doi:10.1021/acsbiomaterials.4c00376

BibTeX
@article{Wan2024,
  author = {Wan, Yu and Cao, Yifei and Hu, Dandan and Lai, Qiuyue and Liu, Yumeng and Chen, Yuan and Wu, Mingyu and Feng, Shun},
  title = {Biomimetic Cancer-Targeting Nanoplatform Boosting AIEgens-Based Photodynamic Therapy and Ferroptosis by Disrupting Redox-Homeostasis},
  journal = {ACS Biomaterials Science & Engineering},
  year = {2024},
  doi = {10.1021/acsbiomaterials.4c00376}
}
Kostenlos starten →